Fig. 2: The BioFLIPI is an improved prognostic risk model. | Blood Cancer Journal

Fig. 2: The BioFLIPI is an improved prognostic risk model.

From: Lack of intrafollicular memory CD4 + T cells is predictive of early clinical failure in newly diagnosed follicular lymphoma

Fig. 2

A Distribution of the FLIPI subgroups within CD4 + expression (left) and BioFLIPI risk groups (right). B Forest plots showing the association between FLIPI and BioFLIPI risk groups and early failure in the pooled cohort (N = 496) of follicular lymphoma patients. C and D Kaplan–Meier curves representing event free survival (C) and overall survival (D) in the pooled cohort of follicular lymphoma patients classified by BioFLIPI risk groups.

Back to article page